These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. From Primary Data to Ethnopharmacological Investigations on Bottoni M; Martinelli G; Maranta N; Sabato E; Milani F; Colombo L; Colombo PS; Piazza S; Sangiovanni E; Giuliani C; Bruschi P; Vistoli G; Dell'Agli M; Fico G Plants (Basel); 2024 Feb; 13(4):. PubMed ID: 38498568 [TBL] [Abstract][Full Text] [Related]
24. Biological activity of intervenolin analogs with a phenyl substituent. Abe H; Kawada M; Igarashi M; Ohba SI; Hayashi C; Sakashita C; Watanabe T; Shibasaki M J Antibiot (Tokyo); 2017 Oct; ():. PubMed ID: 29018268 [TBL] [Abstract][Full Text] [Related]
25. Medicinal plant activity on Helicobacter pylori related diseases. Wang YC World J Gastroenterol; 2014 Aug; 20(30):10368-82. PubMed ID: 25132753 [TBL] [Abstract][Full Text] [Related]
26. Strategies used by Abadi ATB World J Gastroenterol; 2017 Apr; 23(16):2870-2882. PubMed ID: 28522905 [No Abstract] [Full Text] [Related]
27. In silico design and in vitro assessment of anti-Helicobacter pylori compounds as potential small-molecule arginase inhibitors. Fiori-Duarte AT; de Oliveira Guarnieri JP; de Oliveira Borlot JRP; Lancellotti M; Rodrigues RP; Kitagawa RR; Kawano DF Mol Divers; 2022 Dec; 26(6):3365-3378. PubMed ID: 34997872 [TBL] [Abstract][Full Text] [Related]
28. In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Spiegel M; Krzyżek P; Dworniczek E; Adamski R; Sroka Z Molecules; 2021 Dec; 27(1):. PubMed ID: 35011255 [No Abstract] [Full Text] [Related]
29. The gastroprotective potential of silibinin against Helicobacter pylori infection and gastric tumor cells. Bittencourt MLF; Rodrigues RP; Kitagawa RR; Gonçalves RCR Life Sci; 2020 Sep; 256():117977. PubMed ID: 32603822 [TBL] [Abstract][Full Text] [Related]
30. Chung JW; Kim SY; Park HJ; Chung CS; Lee HW; Lee SM; Kim I; Pak JH; Lee GH; Jeong JY Gut Liver; 2017 Sep; 11(5):648-654. PubMed ID: 28750485 [TBL] [Abstract][Full Text] [Related]
31. Engineering resveratrol-loaded chitosan nanoparticles for potential use against Helicobacter pylori infection. Spósito L; Fonseca D; Gonçalves Carvalho S; Sábio RM; Marena GD; Bauab TM; Bagliotti Meneguin A; Parreira P; L Martins MC; Chorilli M Eur J Pharm Biopharm; 2024 Jun; 199():114280. PubMed ID: 38588828 [TBL] [Abstract][Full Text] [Related]
32. Search for Potential Inducible Nitric Oxide Synthase Inhibitors with Favorable ADMET Profiles for the Therapy of Helicobacter pylori Infections. Rodrigues RP; Ardisson JS; Ribeiro Gonçalves RC; Oliveira TB; Barreto da Silva V; Kawano DF; Kitagawa RR Curr Top Med Chem; 2019; 19(30):2795-2804. PubMed ID: 31721712 [TBL] [Abstract][Full Text] [Related]